Praxis Precision Medicine (NASDAQ:PRAX) reported quarterly losses of $(3.29) per share which missed the analyst consensus estimate of $(3.17) by 3.79 percent. This is a 15.85 percent decrease over losses of $(2.84) per share from the same period last year.